Riachy R, Vandewalle B, Belaich S, Kerr-Conte J, Gmyr V, Zerimech F, d'Herbomez M, Lefebvre J, Pattou F
Laboratoire d'Endocrinologie Expérimentale, UPRES 1048, Faculté de Médecine, Lille, France.
J Endocrinol. 2001 Apr;169(1):161-8. doi: 10.1677/joe.0.1690161.
We examined whether 1,25 dihydroxyvitamin D(3) (1,25 D(3)), the active form of vitamin D involved in the regulation of the immune system, may also protect human pancreatic islet cells from destruction induced by cytokines. In this study, we specifically investigated the effect of 1,25 D(3) on oxidative stress and major histocompatibility complex (MHC) induction, both implicated in cytokine-induced islet cell dysfunction and destruction. We also investigated the effects of 1,25 D(3) on interleukin (IL)-6, a pleiotropic cytokine implicated in the pathogenesis of immunoinflammatory disorders. Human pancreatic islets, isolated from heart-beating donors, were treated with a combination of three cytokines, IL-1beta+tumor necrosis factor alpha+interferon gamma, in the presence or absence of vitamin D, and compared with with untreated control cells. Metabolic activity was assessed by cell viability and insulin content. Oxidative stress was estimated by heat shock protein 70 (hsp70) expression, cell manganese superoxide dismutase (MnSOD) activity and nitrite release, a reflexion of nitric oxide (NO) synthesis. Variation of immunogenicity of islet preparations was determined by analysis of the MHC class I and class II transcripts. Inflammatory status was evaluated by IL-6 production. After 48 h of contact with cytokines, insulin content was significantly decreased by 40% but cell viability was not altered. MHC expression significantly increased six- to sevenfold as well as NO and IL-6 release (two- to threefold enhancement). MnSOD activity was not significantly induced and hsp70 expression was not affected by the combination of cytokines. The addition of 1,25 D(3) significantly reduced nitrite release, IL-6 production and MHC class I expression which then became not significantly different from controls. These results suggest that the effect of 1,25 D(3) in human pancreatic islets cells may be a reduction of the vulnerability of cells to cytotoxic T lymphocytes and a reduction of cytotoxic challenge. Hence, 1,25 D(3) might play a role in the prevention of type 1 diabetes and islet allograft rejection.
我们研究了1,25二羟维生素D(3)(1,25 D(3)),即参与免疫系统调节的维生素D的活性形式,是否也能保护人胰岛细胞免受细胞因子诱导的破坏。在本研究中,我们专门研究了1,25 D(3)对氧化应激和主要组织相容性复合体(MHC)诱导的影响,这两者都与细胞因子诱导的胰岛细胞功能障碍和破坏有关。我们还研究了1,25 D(3)对白细胞介素(IL)-6的影响,IL-6是一种多效性细胞因子,与免疫炎症性疾病的发病机制有关。从心跳骤停的供体分离出的人胰岛,在有或没有维生素D的情况下,用三种细胞因子(IL-1β+肿瘤坏死因子α+干扰素γ)的组合进行处理,并与未处理的对照细胞进行比较。通过细胞活力和胰岛素含量评估代谢活性。通过热休克蛋白70(hsp70)表达、细胞锰超氧化物歧化酶(MnSOD)活性和亚硝酸盐释放(反映一氧化氮(NO)合成)来估计氧化应激。通过分析MHC I类和II类转录本来确定胰岛制剂免疫原性的变化。通过IL-6产生来评估炎症状态。与细胞因子接触48小时后,胰岛素含量显著降低了40%,但细胞活力没有改变。MHC表达显著增加了六至七倍,以及NO和IL-6释放(增强了两至三倍)。MnSOD活性没有被显著诱导,hsp70表达也不受细胞因子组合的影响。添加1,25 D(3)显著降低了亚硝酸盐释放、IL-6产生和MHC I类表达,然后这些指标与对照无显著差异。这些结果表明,1,25 D(3)对人胰岛细胞的作用可能是降低细胞对细胞毒性T淋巴细胞的易感性以及减少细胞毒性攻击。因此,1,25 D(3)可能在预防1型糖尿病和胰岛移植排斥中发挥作用。